Karolinska University Hospital
- Address
- lock Available on a paid plan
Digestive System Diseases
The Karolinska University Hospital conducts imaging research in the field of nuclear medicine. The department of Nuclear medicine and hospital Physics focuses on advanced PET techniques. These studies target Crohn's disease to improve disease monitoring.
- Molecular imaging of intestinal inflammation
- Evaluation of novel radiotracers for disease activity
- Linking imaging biomarkers with patient‑reported outcomes
The effort aims to enhance diagnosis and guide personalized treatment decisions for patients with inflammatory bowel conditions in Huddinge, Sweden.
Neoplasms
Researchers are applying PARP-PET to visualize DNA repair activity. The focus is on solid tumors to refine treatment planning. The overarching goal is to enhance care for cancer patients.
- Imaging of DNA repair pathways in cancer
- Assessing therapeutic response with molecular PET
- Developing personalized imaging strategies for tumor management
This work integrates cutting‑edge physics expertise to support more precise oncology care across Europe.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Karolinska University Hospital1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Karolinska University Hospital
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of [11C]AZ14132516 Uptake Alterations Post-Multiple AZD7798 Doses in Crohn's Disease Patients via PET Imaging. | AstraZeneca AB | Phase I | Not Recruiting | Aug 2024 | Mar 2026 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Sparsentan | 1 | Unknown | 2021-12-09 | 2021-12-09 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.